The pharmaceutical industry is set to grow at 6.3% per year (CAGR) reaching $1.12tr by 2022. Incremental advancements in R&D productivity has seen a number of treatments moving rapidly through the pipeline, with biologics contributing up to 50% of the Top 100 product sales by 2022.
What's in this report?
This quick read report picks out key statements and predictions of what drugs and companies
will be dominating the market in 2022. The list is broken down by:
- Product Name
- Generic Name
- Pharmacological Class
- Historical & Projected Sales
This report also contains key statements and predictions of:
- What company will lead worldwide prescription sales
- What company is expected to record the fastest sales growth (CAGR) by 2022
- What are the most valuable R&D projects
- & more